4//SEC Filing
Greenberg Norman Michael 4
Accession 0001209191-20-064720
CIK 0001532346other
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 6:48 PM ET
Size
9.5 KB
Accession
0001209191-20-064720
Insider Transaction Report
Form 4
Atreca, Inc.BCEL
Greenberg Norman Michael
Chief Scientific Officer
Transactions
- Sale
Class A Common Stock
2020-12-17$16.61/sh−5,000$83,051→ 0 total - Exercise/Conversion
Class A Common Stock
2020-12-17$4.56/sh+5,000$22,800→ 5,000 total - Exercise/Conversion
Stock Option (right to buy)
2020-12-17−5,000→ 6,929 totalExercise: $4.56Exp: 2026-05-09→ Class A Common Stock (5,000 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2020.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.25 to $16.98, inclusive. The reporting person undertakes to provide to Atreca, Inc., any security holder of Atreca, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
- [F3]1/4 of the Option vested on 5/2/2017 and 1/48 of the Option vests in equal monthly installments as measured from 5/2/2017. The shares subject to this option are early exercisable, subject to the Issuer's right to repurchase. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time.
Documents
Issuer
Atreca, Inc.
CIK 0001532346
Entity typeother
Related Parties
1- filerCIK 0001773750
Filing Metadata
- Form type
- 4
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 6:48 PM ET
- Size
- 9.5 KB